These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33258019)

  • 1. [Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?].
    Braunisch MC; Bachmann Q; Hammitzsch A; Lorenz G; Geisler F; Schmaderer C; Heemann U; Moog P
    Z Rheumatol; 2021 Jun; 80(5):408-417. PubMed ID: 33258019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey.
    Batıbay S; Koçak Ulucaköy R; Özdemir B; Günendi Z; Göğüş FN
    Int J Clin Pract; 2021 Sep; 75(9):e14442. PubMed ID: 34105856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information.
    Schulze-Koops H; Krüger K; Hoyer BF; Leipe J; Iking-Konert C; Specker C;
    Rheumatology (Oxford); 2021 May; 60(5):2128-2133. PubMed ID: 33502500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
    Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C;
    Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course of the COVID-19 pandemic in pediatric rheumatological patients in Germany during the first 3 years (2020-2022)].
    Klein A; Huppertz HI; Horneff G
    Z Rheumatol; 2024 Sep; 83(7):528-535. PubMed ID: 38844689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].
    Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Krüger K
    Z Rheumatol; 2020 Sep; 79(7):686-691. PubMed ID: 32845393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020].
    Schulze-Koops H; Iking-Konert C; Leipe J; Hoyer BF; Holle J; Moosig F; Aries P; Burmester G; Fiehn C; Krause A; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wagner U; Krüger K; Specker C; ;
    Z Rheumatol; 2020 Sep; 79(7):679-685. PubMed ID: 32757030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic].
    Hasseli R; Pfeil A; Hoyer BF; Lorenz HM; Regierer AC; Richter JG; Schmeiser T; Strangfeld A; Voll RE; Krause A; Schulze-Koops H; Müller-Ladner U; Specker C
    Z Rheumatol; 2021 Sep; 80(7):641-646. PubMed ID: 34196793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
    J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].
    Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H
    Z Rheumatol; 2021 Aug; 80(6):570-587. PubMed ID: 34309739
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
    Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T
    Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey.
    Kahveci A; Gümüştepe A; Güven N; Ataman Ş
    Rheumatol Int; 2022 Apr; 42(4):601-608. PubMed ID: 35165770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The German COVID-19 rheumatism register].
    Hasseli R; Regierer AC; Strangfeld A; Pfeil A;
    Z Rheumatol; 2024 Sep; 83(7):536-543. PubMed ID: 38816582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does methotrexate influence the efficacy of vaccination against SARS-CoV-2?].
    Krüger K;
    Z Rheumatol; 2021 Aug; 80(6):552-554. PubMed ID: 34132881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany.
    Hasseli R; Müller-Ladner U; Keil F; Broll M; Dormann A; Fräbel C; Hermann W; Heinmüller CJ; Hoyer BF; Löffler F; Özden F; Pfeiffer U; Saech J; Schneidereit T; Schlesinger A; Schwarting A; Specker C; Stapfer G; Steinmüller M; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Vagedes D; Wassenberg S; Wilden E; Zeglam S; Schmeiser T
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI51-SI58. PubMed ID: 33704418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.
    Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H
    Z Rheumatol; 2021 Dec; 80(Suppl 2):33-48. PubMed ID: 34491403
    [No Abstract]   [Full Text] [Related]  

  • 17. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.
    Tam LS; Tanaka Y; Handa R; Li Z; Lorenzo JP; Louthrenoo W; Hill C; Pile K; Robinson PC; Dans LF; Hsu LY; Lee SM; Cho J; Hasan ATMT; Salim B; Samreen S; Shaharir SS; Wong P; Chau J; Danda D; Haq SA
    Int J Rheum Dis; 2021 Jun; 24(6):733-745. PubMed ID: 33945214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Look after the COVID-19 pandemic: Mortality rates among patients with rheumatic diseases.
    Çimen Güneş E; Çolak S; Şenlik ZB; Tekgöz E; Altunay K; Özdemirkan T; Aytaç BC; Şimşek AÇ; Çınar M; Yılmaz S
    Int J Rheum Dis; 2024 Mar; 27(3):e15129. PubMed ID: 38514928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic.
    Akintayo RO; Bahiri R; El Miedany Y; Olaosebikan H; Kalla AA; Adebajo AO; Migowa AN; Slimani S; Koussougbo OD; Kawther BA; Akpabio AA; Ghozlani I; Dey D; Hassan WA; Govind N; Makan K; Mohamed A; Genga EK; Ghassem MKA; Mortada M; Hamdi W; Wabi MO; Tikly M; Ngandeu-Singwe M; Scott C
    Clin Rheumatol; 2021 Sep; 40(9):3445-3454. PubMed ID: 32876786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
    Schmeiser T; Broll M; Dormann A; Fräbel C; Hermann W; Hudowenz O; Keil F; Müller-Ladner U; Özden F; Pfeiffer U; Saech J; Schwarting A; Stapfer G; Steinchen N; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Wassenberg S; Wilden E; Hasseli R
    Z Rheumatol; 2020 May; 79(4):379-384. PubMed ID: 32303821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.